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ABSTRACT
Heat shock factor (HSF) is a conserved and highly
potent transcription activator. It is involved in a wide
variety of important biological processes including
the stress response and specific steps in normal
development. Reagents that interfere with HSF
function would be useful for both basic studies
and practical applications. We selected an RNA
aptamer that binds to HSF with high specificity.
Deletion analysis defined the minimal binding motif
of this aptamer to be two stems and one stem–loop
joined by a three-way junction. This RNA aptamer
interferes with normal interaction of HSF with its
DNA element, which is a key regulatory step for HSF
function. The DNA-binding domain plus a flanking
linker region on the HSF (DL) is essential for the
RNA binding. Additionally, this aptamer inhibits
HSF-induced transcription in vitro in the complex
milieu of a whole cell extract. In contrast to the
previously characterized NF-kB aptamer, the HSF
aptamer does not simply mimic DNA binding, but
rather binds to HSF in a manner distinct from DNA
binding to HSF.
INTRODUCTION
Heat shock factor (HSF) is a potent transcription activator
that is highly conserved from yeast to humans. HSF plays
a central role in activating gene expression in response to
environmental stresses including heat shock, and regulates a
wide range of downstream target genes in the genome (1).
A genome-wide study showed that 3% of Saccharomyces
cerevisiae genes are functional targets of HSF. Many are
involved in a wide variety of important cellular functions such
as signal transduction, energy generation, vesicular transport
and chaperone function (2). HSF function is essential for
the stress response, for viability in yeast (3) and for early
development in Drosophila (4). HSF is also involved in the
aging process in Caenorhabditis elegans (5), as well as in
extra-embryonic development in mammals (6). In addition,
downregulating HSF activity sensitizes cancer cells to some
anti-cancer drugs (7).
HSF, which functions during heat shock as a homo-trimer,
has a highly conserved DNA-binding domain and trimer-
ization domain, and a less conserved activation domain.
Trimerized HSF binds tightly to a conserved heat shock ele-
ment (HSE) that is composed of the basic unit, ‘AGAAn’,
arranged as inverted repeats; e.g. a 15 bp sequence containing
three such units, called HSE3 (AGAAGCTTCTAGAAG), is
a good binding target for an HSF trimer (8). In between
the DNA-binding domain and trimerization domain, there is
a ﬂexible linker region that is essential for positioning the
DNA-binding domain in a HSF homotrimer (9). Upon heat
shock or other stresses, the trimerization domain, which con-
tains leucine zipper repeats become available for multi-
merization, and the resulting HSF trimers bind tightly to
HSEs of heat shock genes (1). HSF activates transcription
by further recruitment of other important transcription factors
or complexes such as mediator complex to the heat shock
promoters (10).
A major goal of our laboratory is to identify speciﬁc
reagents that can interfere with particular macromolecular
interactions in order to dissect transcriptional mechanisms
in vitro and in vivo (11,12). Heat shock genes provide an
attractive model system for these studies. Because the HSF/
DNA interaction is a key regulatory step in heat shock gene
activation, generating reagents that can speciﬁcally disrupt
this interaction is critical. RNA aptamers are reagents that
can be selected from a random RNA sequence pool for
their ability to bind tightly to a protein target. Once isolated,
such aptamers can be used to interfere with speciﬁc macro-
molecular interactions for evaluating mechanistic questions
both by simply adding the aptamers to in vitro transcription
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Only a few RNA aptamers have been selected against
transcription factors that recognize speciﬁc DNA sequences.
The best-characterized example is an NF-kB aptamer. This
RNA aptamer has a structure that mimics the structure of
normal DNA element binding to NF-kB, when the aptamer
is bound to the protein (14). This example raises the possib-
ility that transcription factors might have a common nucleic
acid-binding surface for both endogenous and selected nuc-
leic acid molecules (14).
We characterized an HSF aptamer and show here that it
can interfere with the normal interaction of HSF and DNA.
However, this aptamer binds to HSF in a manner mechanist-
ically distinct from that of DNA binding to HSF, demonstrat-
ing that such selected RNA aptamers can bind transcription
factors by mechanisms that do not simply mimic the DNA
element. The elaborate structural features of this HSF apta-
mer, namely a three-way junction structure might account
for some of its surprising properties. Furthermore, the ability
to mechanistically inhibit HSF function also makes this apta-
mer a molecular tool with potential signiﬁcance in clinical
applications where diseases are inﬂuenced by HSF activity.
MATERIALS AND METHODS
Proteins and SELEX
Baculovirus expressed dHSF was puriﬁed as described else-
where (15). MBP-fused dHSF and His-tagged full-length
yHSF were expressed in Escherichia coli and puriﬁed with
conventional afﬁnity column chromatography. Partial yHSF
proteins and point mutation yHSFs were expressed and
puriﬁed using previously described protocols (9). The linker
peptide (underlined) and extra residues for dimeriza-
tion (WQFENENFIRGREDLLEKIIRQKGSSNACLIN) was
synthesized on a continuous ﬂow PerSeptive Biosystems
(Framingham, MA) peptide synthesizer and puriﬁed to
homogeneity by reversed-phase C18-high-performance liquid
chromatography.
The selection of RA1-HSF aptamer was performed using
MBP-fused dHSF and the SELEX method based on nitrocel-
lulose ﬁlter partitioning with ﬁnal selection by electrophoretic
mobility shift assay (EMSA) (11). We preformed 14 cycles
of selection and selected 5 identical sequences (named as
‘RA1-HSF’), from a total of 20 sequences cloned from the
ﬁnal stage pool. The remaining 15 sequences showed no
detectable HSF-binding activity.
EMSA
The general scheme of EMSA was adopted and modiﬁed
from previous work (16). RNA probes were internally labeled
with [a-
32P]UTP by using a T7 in vitro transcription kit
(MAXIscript Kit; Ambion, Austin, TX). DNA is end-labeled
with [a-
32P]ATP with T4 polynucleotide kinase. The 10 ml
binding solution contains 1· binding buffer (10 mM Tris,
40 mM KOAc and 1 mM MgCl2, pH 7.6), 1 mg carrier
yeast RNA, 4 mg carrier BSA, 5 mM DTT, 10% glycerol,
6 U of Superase-In (Ambion), plus protein and labeled
RNA. The concentration of the labeled RNA probe was
below 1 nM in most experiments to ensure an excess protein
concentration. Protein and RNA were incubated at room
temperature for 30 min, and 10 min at 4C before loading
on a 6 or 9% native polyacrylamide gel or a 2% agarose
gel. The polyacrylamide gels contained 1/4 TBE buffer and
1 mM MgCl2, and the agarose gels contained 1· TAE buffer.
Gels were run at 100–150 V at 4C for 1–2 h. They were then
dried and exposed over a phosphorimager plate, and scanned
after 4 h overnight exposure using a STORM image scanner.
Competition assay
Competition assays were performed in the same binding solu-
tion as described for EMSA. For DNA and RNA competition
assays, RNA aptamer probes were labeled with [a-32P]UTP
as described above. The HSE3 DNAs and the HSE3 RNA
were end-labeled with [g-
32P]ATP with T4 polynucleotide
kinase. An excess of a particular ice-cold DNA or RNA was
co-incubated with the labeled RNA or DNA and HSF protein
for 30 min at room temperature, and examined by EMSA. In
the protein–protein competition assay (Figure 4B), the RA1-
HSF aptamer was labeled as above, and different amounts of
each protein construct were incubated together with the RNA
for 30 min at room temperature to allow competition for the
binding to the RNA. Samples were submitted to gel electro-
phoresis and exposed as described above for EMSA.
Double-strand annealing experiment
Annealing of the two RNA strands was performed by incubat-
ing the labeled RNA strand A and unlabeled RNA strand B at
70Ci n1 · binding buffer for 10 min, and the temperature was
reduced to room temperature gradually. Both the annealed
RNA mixture and labeled single strand of RNA alone were
incubated with 40 nM dHSF at room temperature for 30 min
before loading on to an agarose gel for the EMS assay.
In vitro transcription assay
Yeast Strain BJ1991 (prb1 pep4 gal2 leu2 trp1 ura3) was
grown in yeast extract/peptone/dextrose (YEPD) to an
OD600 of 2.0. Cells were harvested, and whole cell extracts
were prepared by using a mortar and pestle as described
previously (17). Protein concentration was determined by
Bradford assay. In vitro transcription was performed based
on a protocol adapted from Ref. (12). Brieﬂy, transcription
reactions were carried out at room temperature in a 25 ml ﬁnal
lume using a plasmid template pJJ461 (200 ng) that contains
an upstream HSE (CTTCTAGAAGCTTCTAGAAG) and the
yeast CYC1 promoter fused to a 290 nt G-less cassette. Yeast
whole cell extract (120 mg) was incubated for 2 min in tran-
scription buffer [20 mM HEPES, pH 7.6, 100 mM potassium
glutamate, 10 mM MgOAc, 5 mM EGTA, 2.5 mM DTT,
10 mM ZnSO4, 10% glycerol, 20 U of RNase Inhibitor
(SUPERase-In; Ambion) plus an ATP regeneration system
(3 mM ATP, 30 mM creatine phosphate and 150 ng of creat-
ine kinase)]. Aptamers and recombinant proteins were added
to the extract mixture at the concentrations indicated, together
with the addition of DNA template. Transcription was initi-
ated with NTPs (10 mCi of [a-
32P]UTP, 50 mM UTP,
250 mM CTP and ATP, ﬁnal concentrations) and terminated
with stop solution (10 mM Tris, 20 mM EDTA, 0.2 M NaCl,
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samples were incubated at 37C for 30 min, digested with
proteinase K in the presence of SDS (2%) for 20 min before
being phenol/chloroform extracted and ethanol precipitated.
RNA products were separated on a 6% polyacrylamide
sequencing gel.
RESULTS
Definingthe critical sequences of the RA1-HSFaptamer
required for HSF binding
An RNA aptamer against HSF was selected from a pool of
10
14 RNA molecules that can bind to bacterially expressed
dHSF. The mfold program (18) predicted that the most
stable RNA secondary structure is composed of a three-way
junction radiating three different stem–loops, which we
deﬁned as stem–loops 1, 2 and 3 as shown in Figure 1A.
The predicted stem–loop 1 is essential for the aptamer func-
tion and could not be shortened (data not shown). We deﬁned
the minimal functional motif by trimming both stem–loops 2
and 3 in a distal-to-central manner and testing the resulting
RNAs for HSF-binding activity by EMSA. A 45 nt sequence
was ﬁnally deﬁned as the minimal structure that still carries
detectable binding activity: 1 bp less from either stem–loop
2 or 3 resulted in sharp decrease of binding activity (Figure 1B
and C). This minimal aptamer structure, which we refer to
as the CORE (Figure 1D), is relatively large and complex
compared to most other minimal functional motifs from
other identiﬁed RNA aptamers, indicating that its interaction
with HSF is likely to be extensive. The apparent binding
Kd for full-length aptamer binding to the full-length dHSF
is 20–40 nM and 40–80 nM for the CORE aptamer. However,
we cannot rule out that certain bases in the middle of the
CORE sequence may be deleted or replaced without com-
promising aptamer-binding activity.
Figure 1. Characterization of the HSF-binding aptamer RA1-HSF. (A) The secondary structure of RA1-HSF predicted by the mfold program. (The arrow points
to a region on stem–loop 3 that has an ‘AGAAU’ sequence, which is similar to a repeating unit of an HSE.) (B) A sketch of a deletion series of constructs that
were designed and used to define the minimized binding motif of the aptamer. Each deletion construct trims one more base pair from either stem–loop 2 or 3,
keeping the other stem–loop end connected with either the original loop or an extra tetraloop (CUUCGG, represented by a small square). The constructs marked
with a star mark were chosen for analysis by EMSA shown in (C). (C) The HSF binding of labeled constructs examined by EMSA, where Core is the minimized
RNA-binding construct shown in (D); A3t4 is the Core shortened by 1 bp on stem–loop 3; A2t2 is the Core shortened by 1 bp on stem–loop 2; RA1-HSF is the
original full-length aptamer shown in (A). (The shifted positions for the different RNA–protein complexes are similar because the size difference between RNA
constructs is relatively small compared to the full-length dHSF trimer/RNA complex). (D) The predicted secondary structure of the ‘Core’ is the same as that
shown in the squared region of (B). (Note that there is a tetraloop holding the trimmed stem–loop 2 end in the real construct.) (E) The binding curve for RA1-HSF
aptamer to HSF protein. The percentage of bound fraction of RA1-HSF to the protein versus total RNA (y-axis.). The concentration of HSF protein in nM
(x-axis). The error bars represent standard errors from three independent EMSA experiments (except for the 10 nM point, which shows the range from two
experiments).
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aptamer by a double-strand annealing experiment
To test whether the three-way junction structure that was
predicted by mfold is the active conformation, we sought to
assemble this structure by an independent method, where
extra base pairing on stem–loops 2 and 3 ensures the
formation of the three-way junction. We designed a double-
stranded RNA annealing experiment where the CORE
aptamer sequence was divided between two complementary
RNA molecules (Figure 2A and B). We tested whether
annealing of these two RNA molecules could reconstruct
the aptamer-binding activity. If the real secondary structure
was different from the predicted structure, this reconstruction
of activity would very likely fail. The additional base pairs
lock in two of the predicted stems and minimize the potential
for additional structures involving bases in the third stem–
loop. The annealing of these two RNAs produced strong
HSF-binding activity as tested by EMSA, whereas individual
RNAs alone had no activity (Figure 2C). These results pro-
vided an independent test of the three-way junction nature
of the aptamer structure. Furthermore, this experiment sug-
gested another level for modulating the activity of an aptamer
by ‘heterodimer design’. The fact that the function of an apta-
mer depends on the presence of two separate RNA molecules
provides a strategy for tightly controlling its activity.
RA1-HSF binds specifically to the HSF protein
Because numerous nucleic acid-binding proteins exist in
a cell, it is important to show the HSF aptamer binds with
speciﬁcity to its proposed target, HSF. First, we examined
the speciﬁcity of this aptamer by testing the interaction of
this aptamer to several other transcription factors (TBP,
GAGA factor, Gal4-VP16) that bind to DNA. None of
them showed any binding activity to the aptamer even at a
protein concentration of 250 nM (Figure 3A). Second, the
speciﬁcity of the aptamer/HSF interaction was tested in the
background of whole, insect-cell lysate proteins. Insect cul-
ture cells (SF9 cells) that do or do not express Drosophila
Strand A+ Strand B Strand A Strand B
Figure 2. Test of the three-way junction structure of the aptamer by a double-strand annealing experiment. (A) A schematic illustration of the double-strand
annealing experiment. (B) The secondary structures for strand A and strand B alone as predicted by the mfold program; and strand A annealed with strand B.
(C) EMSA showing the binding Hsf to strand A, strand B alone or annealed strand A and strand B.
Figure 3. Testing the specificity of the aptamer RNA–protein interaction.
(A) The interactions of labeled RA1-HSF RNA with different transcription
factors, TBP, GAGA and Gal4-VP16 (G4-VP) were tested by EMSA.
(B) EMSA performed by using labeled RA1-HSF in SF9 cell lysate with
vector expressing dHSF(+) or with empty vector(). (C) Competition assay
done by using 100-fold unlabeled yeast RNA (yR), HSE3 dsRNA (HSE3R),
HSE3 dsDNA with a single point mutation (HSE3m), and HSE3 dsDNA
(HSE3) to compete with labeled RA1-HSFaptamer binding to HSF protein.
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32P-labeled RA1-HSF. The aptamer RNA could form a single
RNA–protein complex band only with the cell lysate that
expresses dHSF, which indicated that this aptamer speciﬁc-
ally recognizes dHSF at least in the background of whole
insect cell lysates (Figure 3B).
Interestingly, a double-stranded region on the stem–loop
3 of the aptamer has the sequence ‘AGAAU’, which corres-
ponds to the 5 bp repeating unit of the HSE DNA sequence
(Figure 1A). However, a dsRNA containing the sequence
resembling HSE3 dsDNA failed to compete with the labeled
aptamer for binding to HSF (Figure 3C). This result ruled out
the possibility that this aptamer binds to HSF simply through
the part of double-stranded RNA that carries the corres-
ponding sequence of HSE DNA, though this is not out of
expectation given the difference of helix structure between
DNA and RNA (19).
This aptamer binds both bacterially expressed dHSF and
insect-expressed dHSF (Baculovirus expression system)
with almost the same afﬁnity. This implies that the binding
is not inﬂuenced signiﬁcantly by the post-translational modi-
ﬁcation of HSF (data not shown). Interestingly this aptamer
also binds to yeast HSF1 protein with afﬁnity similar to
Drosophila HSF. Therefore, we used a yHSF deletion series
to deﬁne the minimal region on HSF for aptamer binding in
the following experiments.
The DNA-binding domain plus its flanking linker
region (DL) of the HSF protein is essential for binding
aptamer RNA
Given that the aptamer RNA and HSE3 DNA are competitive
in their binding to HSF, we anticipated that the RNA was
likely to bind to the DNA-binding surface of the HSF protein,
perhaps by structurally simulating HSE DNA. However, we
observed that the interactions of HSF with the RNA aptamer
and with HSE3 DNA show important differences. A previous
study has shown that DNA-binding domain alone is sufﬁcient
for HSE3 DNA binding (9). Surprisingly, the DNA-binding
domain alone is not sufﬁcient for the RNA binding even at
a protein concentration as high as 5 mM (data not shown).
In order to deﬁne the region required for RNA binding, we
used a deletion series of yHSF protein, starting with a peptide
that contained the DNA-binding domain, the conserved 21
amino acid linker, the non-conserved 52 amino acid linker
and the trimerization domain. This construct, which we
refer to as DLT, binds to the aptamer at approximately the
same afﬁnity as the full-length protein. The non-conserved
52 amino acid linker was not required for RNA binding
(compare lanes A and B in Figure 4B), and this part of
Hsf1 is known not to be essential for structural integrity or
in vivo function (9). However, the 21 amino acid conserved
linker was absolutely required for RNA binding (compare
Figure 4. Defining the minimal region on the yHSF that is critical for binding HSF aptamer RNA. (A) A schematic representation showing the yHSF partial
deletion constructs used, where ‘D’ is the DNA-binding domain; ‘L’ is the conserved linker 259–280 plus non-conserved linker 281–332; ‘T’ is the trimerization
domain 333–424; ‘DLT’ is the yHSF construct containing all these three regions; ‘DL’ is the DNA-binding domain plus conserved linker region; ‘DLm’ is the
monomer of DL; ‘DLd’ is the dimer of DL; ‘Lm’ is the monomer of the conserved linker region; and ‘Ld’ is the dimer of the conserved linker region. (B) The
binding activity of RA1-HSF to the yHSF partial proteins [from ‘A’ to ‘G’ in (A)] tested by EMSA. (C) The binding activity of DLm, and DLd, Lm and Ld,
and D alone are tested by a competition assay using an excess of each of these protein constructs to compete the binding of DLT to radiolabeled RA1-HSF.
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ization domain was not required, as long as the peptide con-
taining the DNA-binding domain and linker was dimerized
through an added cysteine near the C-terminus (lane F in
Figure 4B). Because EMSA could fail to detect weak inter-
actions, we also performed a competition experiment. We
used the different HSF domains to compete with the RNA
binding to the DLT construct. The competition results show
that the DL, but not the DNA-binding domain, monomeric
or dimeric linker peptide (Lm, Ld), competes with the DLT
for binding aptamer RNA (Figure 4D). This indicates that
the DL peptide contains the minimal set of domains required
for the aptamer binding.
The RNA aptamer binds to HSF in a manner distinct from
HSE DNA binding to HSF. Though the DNA-binding domain
alone is sufﬁcient for HSE3 DNA binding, some mutations
within the conserved protein linker region can dramatically
decrease the DNA-binding activity presumably by changing
the positional relationships of the DNA-binding domains
in the trimer HSF (20). To test whether the linker require-
ments for the HSF binding to RNA are similar to those for
HSF binding to DNA, we used six different point mutation
versions of the DLT construct that varied at ﬁve conserved
residues within the 21 amino acid conserved linker region
(Figure 5). EMSA results showed no correlation between
DNA binding and RNA binding to the proteins containing
these point mutations. Some mutations diminished the
DNA binding but not RNA binding, whereas some mutations
diminished RNA binding but not the DNA binding (Figure 5).
We conclude that the binding pattern of the RNA aptamer to
HSF is distinct from that of DNA binding to HSF. The results
also further conﬁrm that the conserved linker region is critical
for the HSF interaction with the RNA aptamer.
The HSF RNA aptamer inhibits HS transcription in
yeast cell extracts, and this inhibition activity is
reversed by the addition of DL
The result that this aptamer could compete with DNA binding
to HSF indicates that this aptamer could downregulate HSF
transcriptional activity. We tested the effects of this aptamer
on heat shock (HS) genes by using a yeast cell extract in vitro
transcription system. RA1-HSF RNA was added into the yeast
whole cell extract, which contains necessary components for
HS transcription and a reporter yeast gene whose promoter
has an HSE3 element (Materials and Methods). This yeast
transcription system has been described and applied success-
fully to determine inhibitory effects of other aptamers against
other transcription factors previously (12). The results in
Figure 6 show that the RA1-HSF RNA aptamer inhibits the
transcription on HS promoter at a concentration as low as
10 nM. Moreover, adding puriﬁed recombinant DL protein
reversed this transcription inhibition (Figure 6). This result
not only conﬁrms the inhibitory activity of this aptamer on
HS genes at least in a yeast cell extract transcription system,
but also demonstrates that the inhibitory activity of this apta-
mer is speciﬁcally through the HSF interaction with DNA,
since the presence of extra DL could reverse the inhibitory
effects completely. In contrast, adding DL alone caused insig-
niﬁcant change to the overall transcription, which ruled out
the possibility that DL reversed the inhibition by stimulating
transcription through an independent activation pathway.
By using DL instead of full-length yHSF, we avoided the pos-
sibility that the additional recombinant yHSF may squelch
transcription by binding other proteins that interact with
other domains of yHSF. Thus, the RNA aptamer appears to
inhibit transcription through a speciﬁc interaction with the
DL domain of HSF and, moreover, these results demonstrated
the potential utility of aptamers in dissecting of transcrip-
tional mechanisms.
12 3 4 5 6
Figure 6. The HSF RNA aptamer inhibits transcription in yeast cell lysate.
The major transcription products identified with arrows. Lane 1 shows the
no-template control while all the remaining lanes show transcription from
the plasmid template pJJ461 which contains an upstream HSE; lanes 3 and 4
are transcription in the presence of RA1-HSF; lane 5 is the transcription in
the presence of DL; lane 6 is in the presence of both RA1-HSF and DL.
Concentrations of each component added are indicated in the figure.
Figure 5. The RNA aptamer binds to the HSF in a distinct manner with DNA
HSE3 binding to the HSF. (A) Comparing the binding of the RNA aptamer
and the DNA HSE3 to the DLT HSF and to two of the mutated DLT HSF
derivatives, LM2 (R274M) and LM5 (F261A). (B) A summary of binding
activity of the RNA aptamer and the DNA HSE3 to DLT-yHSF and six point-
mutant derivatives where ‘+++’ shows binding activity similar to wild-type
HSF; ‘+’ shows lower than WT but detectable binding activity at a protein
concentration of 1 mM; ‘’ shows non-detectable binding activity at a protein
concentration of 1 mM.
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The HSF aptamer we have selected and characterized here
has an unusually complicated secondary structure. The pre-
dicted secondary structure has three stem–loops connected
by a three-way junction. Serial deletions of the aptamer
deﬁned a minimized aptamer-binding motif. This secondary
structure has been further conﬁrmed by independently assem-
bling a homologous three-way junction using two separate
RNAs, whose annealing produced full HSF-binding activity.
Because complicated RNA structures with one or more
branches, account for only <1% of the secondary structures
in a 40mer random sequence pool as used here (21), the func-
tional domain of a selected RNA aptamer is often a single
stem–loop structure. Why did we not select simpler HSF
aptamers? Perhaps the starting pool does not contain a simple
structured RNA that binds tightly to HSF. Also, a more com-
plicated RNA structure may be favored in the selection of an
RNA that binds to the complicated and ﬂexible structure of
HSF protein. For example, the linker region of the HSF,
which is essential for the aptamer binding, is a highly ﬂexible
unstructured region (9).
Most previously characterized RNA aptamers to DNA-
binding proteins were found to bind to the DNA-binding sur-
face of the targeted protein (12,22). In a structural study of an
NF-kB/aptamer complex, Huang et al. (14) found that the
NF-kB RNA aptamer is a DNA mimic, and matches perfectly
the DNA-binding surface of NF-kB. In contrast to the NF-kB
example, our HSF aptamer provides the ﬁrst example of an
RNA aptamer selected to a DNA-binding factor that can com-
pete with DNA but binds to the protein in a manner that is
distinct from DNA binding to the protein. Moreover, even
though the linker region of HSF has been proven to be essen-
tial for the aptamer binding, this does not rule out the possib-
ility that the DNA-binding domain can provide a direct
contribution to the binding.
We have previously generated RNA aptamers as inhibitors
of particular macromolecular interactions of the general tran-
scription factor TATA-binding protein (TBP) (12). Here we
have generated and characterized an RNA aptamer that is a
highly effective inhibitor of a key upstream transcription
activating factor. The fact that this RA1-HSF aptamer can
inhibit HSF-induced transcription in vitro in the complex
milieu of a whole cell extract demonstrates the potential use-
fulness of this aptamer for both in vitro and in vivo studies of
HSF function. To our knowledge, there is no drug that targets
this DNA-binding function of HSF. We envision that the
information derived from this and future studies with this
aptamer will prove useful in the diagnosis and treatment of
diseases that are inﬂuenced by HSF function.
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